Results 1 to 10 of about 11,188,116 (297)

Managing clinical trials [PDF]

open access: yesTrials, 2010
Managing clinical trials, of whatever size and complexity, requires efficient trial management. Trials fail because tried and tested systems handed down through apprenticeships have not been documented, evaluated or published to guide new trialists starting out in this important field.
Kenyon Sara   +2 more
core   +8 more sources

It is unprecedented: trial management during the COVID-19 pandemic and beyond [PDF]

open access: yesTrials, 2020
The COVID-19 pandemic has presented unique challenges for the clinical trial community, both in the rapid establishment of COVID-19 clinical trials and many existing non-COVID-19 studies either being temporarily paused (whether that is a complete pause ...
Eleanor J. Mitchell   +12 more
doaj   +2 more sources

Where do we go from here? – Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals [PDF]

open access: yesTrials, 2020
Background Clinical trials commonly have a dedicated trial manager and effective trial management is essential to the successful delivery of high-quality trials.
Eleanor Mitchell   +10 more
doaj   +2 more sources

LoRaWAN and Urban Waste Management—A Trial [PDF]

open access: yesSensors, 2021
The city of Lisbon, as any other capital of a European country, has a large number of issues regarding managing waste and recycling containers spread throughout the city. This document presents the results of a study promoted by the Lisbon City Council for trialing LPWAN (Low-Power Wide-Area Network) technology for the waste management vertical under ...
Cruz, Nuno   +2 more
openaire   +5 more sources

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

open access: yesCardiac Failure Review, 2020
The coronavirus disease 2019 (COVID-19) pandemic started in Wuhan, Hubei Province, China, in December 2019, and by 24 April 2020, it had affected >2.73 million people in 185 countries and caused >192,000 deaths.
Ernest Spitzer   +6 more
doaj   +1 more source

Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study

open access: yesFrontiers in Pharmacology, 2022
Background: Previous findings on using Glucagon-like peptide-1 receptor agonist (GLP1-RA) as an antidepressant were conflicting, lacking large-scale studies.
Wen-Hsuan Tsai   +8 more
doaj   +1 more source

The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases

open access: yesFrontiers in Pharmacology, 2021
Interleukin-38 (IL-38), a new cytokine of interleukin-1 family (IL-1F), is expressed in the human heart, kidney, skin, etc. Recently, new evidence indicated that IL-38 is involved in the process of different autoimmune diseases. Autoimmune diseases are a
Miao-miao Han   +12 more
doaj   +1 more source

A 12-week, randomized, double-blind study to evaluate the efficacy and safety of liver function after using fermented ginseng powder (GBCK25)

open access: yesFood & Nutrition Research, 2020
Background: Recently, clinical research has suggested that red ginseng components play a role in liver protection and combating fatigue. However, fermented ginseng has not been analyzed for liver-protective or anti-fatigue effects.
Su-Jin Jung   +8 more
doaj   +1 more source

ECONOMIC MARKET DECISIONS AMONG MARGINAL MAIZE FARMERS IN ABUJA, NIGERIA: APPLICATIONS OF DOUBLE HURDLE MODEL AND FACTOR ANALYSIS [PDF]

open access: yesRussian Journal of Agricultural and Socio-Economic Sciences, 2020
This study examined economic market decisions among marginal maize farmers in Abuja, Nigeria: applications of double hurdle model and factor analysis.
Alabi O.O., Oladele A.O., Oladele N.O.
doaj   +1 more source

Immunomodulatory effects of a mycelium extract of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial

open access: yesBMC Complementary and Alternative Medicine, 2019
Background Cordyceps is a traditional Chinese herb that produces various biopharmaceutical effects, including immune-enhancing effects. In this study, we prepared a Cordyceps mycelium culture extract (Paecilomyces hepiali, CBG-CS-2) to confirm its ...
Su-Jin Jung   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy